The American Diabetes Association now recommends GLP-1 RAs for patients with established ASCVD regardless of their A1C and regardless of if the patient is taking metformin, the historically first line medication for T2DM [38]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.